Table 1.

Baseline characteristics

	LA Termination (n=104)	RA Termination (n=24)	Non Termination (n=20)	P
Age	58±10	60±11	58±11	0.72
Males	79%	83%	80%	0.89
AF duration	12 [6,20]*†	23[12,48]*	35[12,72]†	*†<0.001
HTN	27%	23%	28%	0.92
SHD	41%	46%	50%	0.74
Emboli	5%	5%	12%	0.56
HF	19%	8%	26%	0.76
No AAD	2.5 [2,3]	3[1,3]	3[2,3]	0.75
LVEDD	53[48,57]	52[48,61]	54[50,60]	0.33
LVESD	36 [30,41]	35[28,44]	39[34,44]	0.45
LVEF	56±13	59±12	55±14	0.49
LA Para	48±8*	48±7*†	57±9*†	*†<0.001
LA LONG	61±7*	61±7*†	67±9†	*†0.01
LA TRANS	45[42,50]*	43[40,47]*†	51[45,57] †	*†0.009
RA LONG	54[49,58]*	56[52,61]	58[53,66]*	*0.02
RA TRANS	39±7*	42±7	45±8*	*0.005

HTN: hypertension, SHD: structural heart disease; HF: heart failure: AAD: antiarrhythmic drug; LVED left ventricular diastolic and systolic diameter, LA: left atrium; RA: right atrium, Para: parasternal, Long: longitudinal, Trans:transversal

^*†Statistically significant difference between marked variables

Data compared using ANOVA for means, ANOVA on ranks for medians and Chi square for categorical data.